No-mesh group (n = 63) | Mesh group (n = 53) | p value | |
---|---|---|---|
Mean age ± SD (years) | 56 ± 10 | 57 ± 7 | 0.58 |
Median (range) parity | 6 (1–15) | 6 (3–14) | 0.69 |
Mean BMI ± SD (kg/m2) | 30 ± 4 | 30 ± 3 | 0.95 |
Postmenopausal | 39 (62) | 36 (68) | 0.50 |
Postmenopausal with HRT | 6 (10) | 6 (11) | 0.24 |
Prior pelvic surgery | |||
Abdominal hysterectomy | 9 (14) | 4 (8) | 0.50 |
Vaginal hysterectomy | 0 (0) | 1 (2) | |
Vaginal repair | 11 (18) | 12 (22) | |
Vaginal repair > once | 1 (2) | 2 (4) | |
Overall vaginal POP-Q stage | |||
Stage III | 49 (78) | 39 (74) | 0.49 |
Stage IV | 14 (22) | 14 (26) | |
Urodynamic stress urinary incontinence | 10 (16) | 9 (17) | 0.87 |
Mean operating time ± SD (min) | 89 ± 26 | 88 ± 19 | 0.85 |
Mean estimated blood loss ± SD (ml) | 267 ± 222 | 257 ± 205 | 0.81 |
Median (range) hospitalisation length (days) | 4 (2–9) | 4 (2–9) | 0.37 |
Median (range) catheter use (days) | 2 (1–8) | 2 (1–7) | 0.15 |
Median (range) return to ADL (weeks) | 6 (3–10) | 6 (3–10) | 0.14 |
Median (range) period of follow-up (months) | 29 (6–60) | 28 (10–60) | 0.58 |